|
Dr. S Rehan Ahmad is a multidisciplinary scientist whose research bridges microbiology, medicinal chemistry, neurobiology, and precision medicine. Earning his Ph.D. in Microbiology, his pioneering work explores the pharmacogenomics and microbiome-based modulation of neurodegenerative diseases, with a focus on plant-derived therapeutics and molecular docking-driven drug discovery. His research integrates molecular microbiology, analytical chemistry (HPLC-MS), bioinformatics, and nanobiotechnology to advance novel therapeutic strategies. He holds over 30 patents and has published more than 60 peer-reviewed articles in high-impact journals, including Nature, Elsevier, Wiley, Springer, Frontiers and MDPI. He has edited two books published by Elsevier: The Gut Microbiome in Precision Medicine: From Research to Clinical Practice which focuses on the gut microbiome's role in health, and Precision Medicine in Neurodegenerative Diseases: From Research to Clinical Practice, covering personalized medicine for neurodegenerative disorders. His editorial experience is extensive, serving as Academic Editor for PLOS ONE, Editorial Board Member for over 15 international journals, and Guest Editor for JoVE. Recognized for his academic leadership, he serves as Coordinator of the Indira Gandhi National Open University (IGNOU) Study Centre (28166), Centre Superintendent (28166), and Convenor of multiple institutional committees including the Research & Development Cell (RDC), Intellectual Property Rights Cell (IPR), and Institution's Innovation Council (Ministry of Education, Government of India). His teaching experience spans over 12 years in microbiology, neurobiology, medicinal biochemistry, food chemistry, and bioinformatics, mentoring more than 40 postgraduates and three doctoral researchers. |
